Linda N. Liu
Keine laufenden Positionen mehr
Karriereverlauf von Linda N. Liu
Ehemalige bekannte Positionen von Linda N. Liu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEXTCURE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 | 01.02.2022 |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2007 | 01.08.2015 |
| MAXCYTE, INC. | Corporate Officer/Principal | 01.01.2000 | 01.01.2007 |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.1999 | 01.01.2000 |
Ausbildung von Linda N. Liu
| Wuhan University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| China | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MAXCYTE, INC. | Health Technology |
| NEXTCURE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
- Börse
- Insiders
- Linda N. Liu
- Erfahrung
